Percutaneous implant of Denver peritone-ovenous shunt: A new opportunity for the interventional radiologist;L'impianto percutaneo dello shunt peritoneo-venoso di Denver: Una nuova opportunità per il radiologo interventista

Radiologia Medica

Volumn 102, Issue 3, 2001, Pages 154-158

  Spreafico, Carlo ^a   Patelli, Gianluigi ^a   Lanocita, Rodolfo ^a   Di Tolla, Giuseppe ^a   Marchianò, Alfonso ^a   Frigerio, Laura ^a   Garbagnati, Francesco ^a   Ticha, Vladimira ^a   Damascelli, Bruno ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Denver peritoneovenous shunt; Interventional radiology

Indexed keywords

ADULT; AGE; ARTICLE; ASCITES; COMPARATIVE STUDY; FEMALE; FOLLOW UP; HUMAN; INSTRUMENTATION; INTERVENTIONAL RADIOLOGY; LIVER FAILURE; MALE; METHODOLOGY; MIDDLE AGED; NEOPLASM; PERITONEUM VEIN SHUNT; SEX DIFFERENCE; TIME;

ADULT; AGE FACTORS; ASCITES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER FAILURE; MALE; MIDDLE AGED; NEOPLASMS; PERITONEOVENOUS SHUNT; RADIOLOGY, INTERVENTIONAL; SEX FACTORS; TIME FACTORS;

EID: 0035459757     PISSN: 00338362     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Campioni N, Vitucci C, Di Iuri S e Coll: La nostra esperienza sull' impiego delle valvole di LeVeen nelle asciti di natura neoplastica. Acta Oncologica 1: 141, 1980.
2. Campioni N, Vitucci C, Guglielmi C e Coll: Neoplastic ascites as elective indications for peritoneo-venous shunting. It J Surg Sci 12 (3): 201-205, 1982.
3. LeVeen HH, Christaudias G, Moon IP e Coll: Peritoneo-venous shunting for ascites. Ann Surg 180: 580-591, 1974.
4. Lund RH, Newkirk JB: Peritoneovenous shunting system for surgical management of ascites. Contemp Surg 14: 31-45, 1979.
5. Edney JA, Adella H, Armstrong D: Peritoneovenous shunts palliate malignant ascites. Am J Surg 158: 598-601, 1989.
6. Rubinstein D, McInnes I, Dudley F: Morbidity and mortality after peritoneovenous shunt surgery for refractory ascites. Gut 26: 1070-1073, 1985.
7. Sauter RG, Wells C, Tarin D e Coll: Surgical and pathologic complications associated with peritoneovenous shunts in management of malignant ascites. Cancer 55: 1973-1978, 1985.
8. Shepard KE, Miller BJ: Peritoneovenous shunts-devices of last resort. Can J Surg 31: 444-447, 1988.
9. Appelquist P, Silvo J, Salmeda L e Coll: On the treatment and prognosis of malignant ascites; is survival time determined when the abdominal paracentesis is needed? J Surg Oncol 20: 238-242, 1982.
10. Greenway B, Johnson PJ, Williams R: Control of malignant ascites with spironolactone. Br J Surg 69: 441-442, 1982.
11. Quazi R, Savlov ED: Peritoneovenous shunt for palliation of malignant ascites. Cancer 49: 600-602, 1982.
12. Reinhold RB, Lockich JJ, Tomashefski J e Coll: Management of malignant ascites with peritoneovenous shunting. Am J Surg 145: 455-457, 1983.
13. Soederlund C: Denver Peritoneovenous shunting for malignant or cirrhotic ascites. Scand J Gastroenterol: 21, 1161-1172, 1986.
14. Campioni N, Pasquali Lasagni R, Vitucci C e Coll: Peritoneovenous shunt and neoplastic ascites: A 5-year experience report. J Surg Oncol 33: 31-35, 1986.
15. Shan Wang B, Heacock EH, Collins KH e Coll: Stimulatory effects on various immunologic responses by ascites fluid from patients with metastatic malignancy. Clin Immunol Immunopath 21: 83-93, 1981.